Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

10.56
Delayed Data
As of Dec 05
 -0.35 / -3.21%
Today’s Change
7.20
Today|||52-Week Range
16.80
-32.87%
Year-to-Date
Why Omeros Corporation Stock Popped 47.9% in November
Dec 05 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close10.91
Today’s open11.10
Day’s range10.48 - 11.41
Volume820,671
Average volume (3 months)608,388
Market cap$453.2M
Dividend yield--
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+16.43%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc-0.40-2.57%
NERVMinerva Neuroscience...+0.15+1.15%
FLMLFlamel Technologies ...-0.42-3.82%
CYTKCytokinetics Inc+0.10+0.90%
Data as of 12/05/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs